New potential players in hepcidin regulation.
作者信息
Chappell Maxwell, Rivella Stefano
机构信息
Division of Hematology, Department of Pediatrics, Children's Hospital of Philadelphia, Cell and Molecular Biology Graduate Group, University of Pennsylvania, Abramson Research Center, Philadelphia, PA, USA.
Division of Hematology, Department of Pediatrics, Children's Hospital of Philadelphia, Cell and Molecular Biology Graduate Group, University of Pennsylvania, Abramson Research Center, Philadelphia, PA, USA
出版信息
Haematologica. 2019 Sep;104(9):1691-1693. doi: 10.3324/haematol.2019.224311.
Abstract
摘要
相似文献
1
New potential players in hepcidin regulation.铁调素调节中的新潜在参与者。
Haematologica. 2019 Sep;104(9):1691-1693. doi: 10.3324/haematol.2019.224311.
2
New thiazolidinones reduce iron overload in mouse models of hereditary hemochromatosis and β-thalassemia.新型噻唑烷二酮类化合物可降低遗传性血色素沉着症和β-地中海贫血小鼠模型中的铁过载。
Haematologica. 2019 Sep;104(9):1768-1781. doi: 10.3324/haematol.2018.209874. Epub 2019 Feb 21.
3
Liver iron concentrations and urinary hepcidin in beta-thalassemia.β地中海贫血患者的肝脏铁浓度和尿铁调素
Haematologica. 2007 May;92(5):583-8. doi: 10.3324/haematol.10842.
4
Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major.血清铁调素作为重型β地中海贫血严重铁过载的诊断标志物。
Indian J Pediatr. 2017 Oct;84(10):745-750. doi: 10.1007/s12098-017-2375-4. Epub 2017 Jun 10.
5
Late-onset Hemochromatosis: Co-inheritance of β-thalassemia and Hereditary Hemochromatosis in a Chinese Family: A Case Report and Epidemiological Analysis of Diverse Populations.迟发性血色素沉着症：一个中国家庭中β地中海贫血与遗传性血色素沉着症的共同遗传：病例报告及不同人群的流行病学分析
Intern Med. 2018 Dec 1;57(23):3433-3438. doi: 10.2169/internalmedicine.8628-16. Epub 2017 Sep 25.
6
Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major: Correspondence.血清铁调素作为重型β地中海贫血严重铁过载的诊断标志物：通信
Indian J Pediatr. 2017 Dec;84(12):967-968. doi: 10.1007/s12098-017-2472-4. Epub 2017 Nov 2.
7
Hepcidin agonists as therapeutic tools.亚铁螯合肽激动剂作为治疗工具。
Blood. 2018 Apr 19;131(16):1790-1794. doi: 10.1182/blood-2017-11-737411. Epub 2018 Mar 9.
8
Hepcidin and Thalassemia.铁调素与地中海贫血
Indian J Pediatr. 2017 Oct;84(10):731-732. doi: 10.1007/s12098-017-2439-5. Epub 2017 Aug 24.
9
A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: correlation with hepatic mRNA expression in established and novel models of dysregulated iron homeostasis.一种针对小鼠铁调素-1的竞争性酶联免疫吸附测定法：与铁稳态失调的既定模型和新模型中肝脏mRNA表达的相关性
Haematologica. 2015 Feb;100(2):167-77. doi: 10.3324/haematol.2014.116723. Epub 2014 Nov 25.
10
Peripheral expression of hepcidin gene in Egyptian β-thalassemia major.埃及重型β地中海贫血患者中hepcidin基因的外周表达
Gene. 2015 Jun 15;564(2):206-9. doi: 10.1016/j.gene.2015.03.048. Epub 2015 Mar 25.
引用本文的文献
1
HFE-Related Hemochromatosis May Be a Primary Kupffer Cell Disease.与HFE相关的血色素沉着症可能是一种原发性库普弗细胞疾病。
Biomedicines. 2025 Mar 10;13(3):683. doi: 10.3390/biomedicines13030683.
2
A Prospective Observational Study Analyzing the Diagnostic Value of Hepcidin-25 for Anemia in Patients with Inflammatory Bowel Diseases.一项前瞻性观察研究分析了铁调素-25 对炎症性肠病患者贫血的诊断价值。
Int J Mol Sci. 2024 Mar 22;25(7):3564. doi: 10.3390/ijms25073564.
3
Characterization of acquired anemia in children by iron metabolism parameters.铁代谢参数对儿童获得性贫血的特征描述。
Sci Rep. 2022 Feb 17;12(1):2721. doi: 10.1038/s41598-022-06574-0.
4
A farewell to phlebotomy-use of placenta-derived drugs Laennec and Porcine for improving hereditary hemochromatosis without phlebotomy: a case report.告别放血术——使用胎盘来源药物 Laennec 和 Porcine 治疗遗传性血色素沉着症而无需放血：一例报告。
J Med Case Rep. 2022 Jan 23;16(1):26. doi: 10.1186/s13256-021-03230-5.
5
SLN124, a GalNac-siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron-overload in a mouse model of β-thalassaemia.SLN124，一种针对跨膜丝氨酸蛋白酶 6 的 GalNac-siRNA，与去铁酮治疗联合使用可减少β-地中海贫血小鼠模型中的无效红细胞生成和肝脏铁过载。
Br J Haematol. 2021 Jul;194(1):200-210. doi: 10.1111/bjh.17428. Epub 2021 May 4.
本文引用的文献
1
New thiazolidinones reduce iron overload in mouse models of hereditary hemochromatosis and β-thalassemia.新型噻唑烷二酮类化合物可降低遗传性血色素沉着症和β-地中海贫血小鼠模型中的铁过载。
Haematologica. 2019 Sep;104(9):1768-1781. doi: 10.3324/haematol.2018.209874. Epub 2019 Feb 21.
2
Iron metabolism under conditions of ineffective erythropoiesis in β-thalassemia.β-地中海贫血无效造血状态下的铁代谢。
Blood. 2019 Jan 3;133(1):51-58. doi: 10.1182/blood-2018-07-815928. Epub 2018 Nov 6.
3
Erythroferrone inhibits the induction of hepcidin by BMP6.促红细胞生成素抑制 BMP6 诱导的铁调素表达。
Blood. 2018 Oct 4;132(14):1473-1477. doi: 10.1182/blood-2018-06-857995. Epub 2018 Aug 10.
4
Hepcidin agonists as therapeutic tools.亚铁螯合肽激动剂作为治疗工具。
Blood. 2018 Apr 19;131(16):1790-1794. doi: 10.1182/blood-2017-11-737411. Epub 2018 Mar 9.
5
Emerging Therapies.新兴疗法。
Hematol Oncol Clin North Am. 2018 Apr;32(2):343-352. doi: 10.1016/j.hoc.2017.11.002. Epub 2017 Dec 15.
6
Synthetic and medicinal perspective of thiazolidinones: A review.噻唑烷二酮类的合成与药用前景：综述
Bioorg Chem. 2017 Dec;75:406-423. doi: 10.1016/j.bioorg.2017.10.014. Epub 2017 Oct 23.
7
Effect of erythropoietin administration on proteins participating in iron homeostasis in Tmprss6-mutated mask mice.促红细胞生成素给药对Tmprss6突变型面具小鼠铁稳态相关蛋白的影响。
PLoS One. 2017 Oct 26;12(10):e0186844. doi: 10.1371/journal.pone.0186844. eCollection 2017.
8
Matriptase-2 suppresses hepcidin expression by cleaving multiple components of the hepcidin induction pathway.Matriptase-2通过切割铁调素诱导途径的多个组分来抑制铁调素的表达。
J Biol Chem. 2017 Nov 3;292(44):18354-18371. doi: 10.1074/jbc.M117.801795. Epub 2017 Sep 18.
9
A Red Carpet for Iron Metabolism.铁代谢的红地毯
Cell. 2017 Jan 26;168(3):344-361. doi: 10.1016/j.cell.2016.12.034.
10
Minihepcidin peptides as disease modifiers in mice affected by β-thalassemia and polycythemia vera.小肝细胞生成素肽作为受β地中海贫血和真性红细胞增多症影响的小鼠的疾病修饰剂。
Blood. 2016 Jul 14;128(2):265-76. doi: 10.1182/blood-2015-10-676742. Epub 2016 May 6.
Zotero 插件